About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
DVAX - Dynavax Technologies...| Previous Close | $8.75 | Open | $9.15 |
| Volume | 2.45M | Market Cap | 899.01M |
| Yield | Last Dividend |
| Biotech Isn't Seeing Much Merger Activit... | 10:00 AM |
| The biotech sector isn't seeing much merger-and-acquisition activity or insider stock purchases, but Dynavax Technologies (DVAX) is one stock to like ... | |
| worth buying post Earnings results? NASD... | 02/27/21 |
| Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest | |
| Dynavax to Present at the Cowen 41st Ann... | 02/16/21 |
| EMERYVILLE, Calif., Feb. 16, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing a... | |
| Dynavax to Report Fourth Quarter and Ful... | 02/11/21 |
| EMERYVILLE, Calif., Feb. 11, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing a... | |
| Dong Yu, Ph.D., Joins Dynavax as Senior ... | 02/08/21 |
| Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that ... | |
| Dynavax Reports Inducement Grants Under ... | 02/04/21 |
| EMERYVILLE, Calif., Feb. 3, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock... | |
| Dynavax and Serum Institute of India Ann... | 02/04/21 |
| /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines,... | |
| Dynavax Announces Exercise of Option to ... | 02/01/21 |
| EMERYVILLE, Calif., Feb. 1, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| Dynavax and CEPI Announce $99 Million in... | 02/01/21 |
| OSLO, Norway AND EMERYVILLE, Calif. , Feb. 1, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX ), a biopharmaceutical company focus... | |
| Dynavax Appoints Kelly MacDonald as Chie... | 01/20/21 |
| EMERYVILLE, Calif., Jan. 20, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing a... | |
| Dynavax Announces Final Immunogenicity a... | 01/07/21 |
| EMERYVILLE, Calif., Jan. 7, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| Dynavax to Present at the H.C. Wainwrigh... | 01/06/21 |
| EMERYVILLE, Calif., Jan. 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| India's Biological E. to start vaccine l... | 12/18/20 |
| BENGALURU: India's Biological E. Ltd plans to start large late-stage trials of its potential COVID-19 vaccine candidate in April next year, according ... | |
| Clover Biopharmaceuticals Announces Posi... | 12/04/20 |
| CHENGDU, China.--(BUSINESS WIRE)--Clover Biopharmaceuticals, a global clinical-stage biotechnology company committed to developing transformative biol... | |
| Biological E to start phase-III trials b... | 11/24/20 |
| Hyderabad: Hyderabad-based Biological E, which recently obtained the drug regulator???s nod to start phase I and II clinical trials of its Covid-19 va... | |
| India's COVID-19 Vaccine COVAXIN's Final... | 11/22/20 |
| NEW DELHI ??? India ???s health minister said on Sunday a locally-developed COVID-19 vaccine candidate could complete its final trials in a month or t... | |
| Biological E. Limited Starts Phase I/II ... | 11/16/20 |
| HYDERABAD, India and HOUSTON and EMERYVILLE, Calif., Nov. 16, 2020 /PRNewswire/ -- Biological E. Limited (BE), a Hyderabad-based vaccines and pharmace... | |
| Dynavax Announces Third Quarter 2020 Fin... | 11/05/20 |
| EMERYVILLE, Calif., Nov. 5, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| Looking Into Dynavax Technologies's Retu... | 11/03/20 |
| During Q2, Dynavax Technologies's (NASDAQ: DVAX) reported sales totaled $2.67 million. Despite a 20.85% in earnings, the company posted a loss of $23.... | |
| Dynavax to Present at the Stifel 2020 Vi... | 11/02/20 |
| EMERYVILLE, Calif., Nov. 2, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing an... | |
| Dynavax to Report Third Quarter 2020 Fin... | 10/22/20 |
| EMERYVILLE, Calif., Oct. 22, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing a... | |
| Dynavax Surges 7% In Pre-Market On Taiwa... | 10/13/20 |
| Medigen Vaccine Biologics (MVC) and Dynavax Technologies (DVAX) have announced that MVC has obtained a Taiwan government subsidy for successfully init... | |
| Dynavax/Medigen's adjuvanted COVID-19 va... | 10/13/20 |
| Dynavax Technologies (NASDAQ:DVAX) and Medigen Vaccine Biologics (MVC) announce that latter has obtained a Taiwan government subsidy in amount of up t... | |
| Medigen's COVID-19 Vaccine Combined with... | 10/13/20 |
| TAPEI, Taiwan and EMERYVILLE, Calif., Oct. 13, 2020 /PRNewswire/ -- Medigen Vaccine Biologics Corporation (MVC) (TPEx: 6547.TWO), a biopharmaceutical ... | |
| Thinking about buying stock in Cassava S... | 09/14/20 |
| NEW YORK, Sept. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, MRSN, SRNE, DVAX, and CODX. To see how Investor... | |
| Worldwide Cancer Vaccines Industry to 20... | 09/08/20 |
| DUBLIN, Sept. 8, 2020 /PRNewswire/ -- The "Cancer Vaccines Market by Technology, Type, Indication and End User: Global Opportunity Analysis and Indust... | |
| Gates Foundation awards $3.4 million for... | 08/18/20 |
| The grant will enable biopharmaceutical company Dynavax Technologies Corporation to increase production capacity for its CpG 1018 advanced adjuvant an... | |
| Dynavax Technologies shares are trading ... | 08/03/20 |
| This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of ??... | |
| The Daily Biotech Pulse: Opko Wins CDC C... | 07/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb... | |
| Thinking about trading options or stock ... | 07/20/20 |
| NEW YORK, July 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DVAX, VXRT, ISRG, F, and LUV. Click a link below then ... | |
| Buy rating | 02/01/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $14.00 to $15.00 | |
| Date | 2021-02-25 (AMC) | Est. (EPS/Rev.) | ($0.24)/ 13.06M |
| Actual (EPS/Rev.) | $-0.14/ $19.55 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| WIDE AWAKE | JOHN KROLIKOWSKI JR | 82.00 % | Follow |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| 1035even | Evan Earle | 61.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
